BioChem, ImmunoGen deal

BCHE and Apoptosis Technology Inc. (Cambridge, Mass.), a 95 percent-owned subsidiary of IMGN, will collaborate to discover and

Read the full 186 word article

How to gain access

Continue reading with a
two-week free trial.